About US
Contact us
-
Under various pressures, Novo Nordisk is cautious on 2018 guidanceNovo Nordisk is navigating a tough stretch thanks to increased competition and new state laws adding to the already-tough pricing pressure on the U.S. insulin market. But the drugmaker has a plan to c2017/11/1
-
Bristol-Myers Squibb could double patient numbers for Opdivo in kidney cancerNow that Bristol-Myers Squibb’s Opdivo has safely posted growth in 2017, all eyes are on what the drug can pull off next year. Its move into a larger kidney cancer market will be central to that equat2017/10/31
-
As generics market stalls, Novartis said to weigh sale of copycat skin medicationsPick up one, cast off another. Just as Novartis agreed to buy a radiotherapy company, it's reportedly considering a selloff of its generic dermatology business, a once-hot field that's been hit by p2017/10/31
-
WPP Health & Wellness invests in online health community to tap patient insightWPP’s latest investment is all about patients. WPP Health & Wellness haspartnered(PDF) with The Mighty, an online community for patients and caregivers, to help boost patient centricity for client2017/10/30
-
Merck hack causes Gardasil sales miss in Q3 as drugmaker borrows from CDCWorking to recover from a damaging cyberattack, Merck reported that its star HPV vaccine missed sales expectations in the third quarter as it had to borrow from the CDC's stockpile to fulfill orders.2017/10/30
-
Aviragen, Vaxart merge to develop oral vaccines for influenza, norovirus and RSVFor some antigens like norovirus and RSV, there are no approved vaccines. For others, like the seasonal flu, immunization rates are often far from ideal. Now, a new company, the product of a merger be2017/10/27
-
Sanofi inks AI pact to learn more about flu vaccine responsesPersonalized vaccines are mostly used in cancer, but what about prophylactic vaccines against infectious diseases? Sanofi Pasteur has tapped Berg's artificial intelligence capabilities to discover bio2017/10/27
-
Roche pulls cancer drug from Greece in fight over government cost cutsSwiss drugmaker Roche has pulled a cancer drug from the Greek market as it does battle again with authorities in the financially exhausted country over steps they have taken against drug prices in an2017/10/26
-
AstraZeneca nets lightning-fast lymphoma nod for Imbruvica rival CalquenceAbbVie and Johnson & Johnson got a scare this Halloween, and it came in the form of an FDA approval for AstraZeneca’s Imbruvica rival. Tuesday, the FDA greenlighted BTK inhibitor Calquence as a2017/10/26
-
Mylan President Rajiv Malik targeted as states expand price fixing suit against top drugmakersMylan President Rajiv Malik and Emcure CEO Satish Mehta were named individually in a vastly expandedcivil lawsuitovergeneric price fixingbrought by nearly every state in the country. The price fixing2017/10/25